Phillies Former Pitcher Released by NL Contender After Brief ThreeGame Stint Payroll Implications for Contending Teams Dow Jones Futures Edge Higher as SP 500 and Nasdaq Hit Record Highs AI Stocks Show Potential Amazon Expands AI Shopping Technology to Retailers Signs Kate Spade as Customer Venture Capital Turns to Mundane Industries AI and Dealmaking Reshape Accounting and Property Management US Consumer Sentiment Remains Depressed Amid Inflation Geopolitical Tensions and Tariff Concerns Samsung Semiconductor Workers Could Receive 400000 Bonus Deal Report Dream Finders Homes Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Texas Capital Bancshares Series B TCBIO Q1 2026 Earnings EPS Exceeds Estimates as Preferred Stock Holds Steady MX Q1 2026 Earnings Strong EPS Beat Provides Some Relief as Revenue Picture Remains Opaque Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones PLPC Q1 2026 Earnings EPS Surges 15 Above Estimates Amid Resilient Operations DAIO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions Star Equity Holdings STRR Gains 243 Advances Toward Resistance at 124 Vera Therapeutics VERA Edges Higher Testing Resistance Amid Steady Volume New Concept Energy Inc GBR Declines 2 Amidst Light Trading Eyes Key Support at 069 Flex Ltd FLEX Edges Higher Consolidating Near Key Resistance Myers Industries MYE Bounces 132 Approaches Key Resistance Near 2339 Custard Apple Gains Traction as Niche Crop Despite Export Hurdles SpaceXs Growth Prospects Tied to Starlink as IPO Prepares for Nasdaq Listing Global Uncertainty Slows Overseas Remittances Under LRS in FY26 RBI Data Shows Should You Take Social Security Early and Switch to Survivor Benefits Later A Case Study at 62 International Aid Sector Faces Breaking Point as Legacy Models Struggle Under Funding Pressures eHealth EHTH Sees Analyst Price Target Boost on Strengthening Operational Performance Asure Software Inc ASUR Q1 2026 Earnings EPS Beats Estimates by 18 Despite Market Skepticism Relmada Therapeutics RLMD Edges Higher as Stock Holds Above Key Support